Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00345501
Status:
COMPLETED
Last Update Posted:
2007-08-24
First Post:
2006-06-27
Brief Title:
Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography andor Intervention
Sponsor:
Onassis Cardiac Surgery Centre
Organization:
Onassis Cardiac Surgery Centre
Study Overview
Official Title:
Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients With Preexisting Renal Dysfunction Undergoing a Coronary Procedure
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The prevention of contrast-mediated nephropathy CMN which accounts for considerable morbidity and mortality remains a vexing problem Contrast induced renal vasoconstriction is believed to play a pivotal role in the CMN mechanism The aim of this study is to examine the efficacy of the prostacyclin analogue iloprost dose 1ngkgmin in preventing CMN in high-risk patients undergoing a coronary procedure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT 2005-001887-30 | None | None | None |